Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.45 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.45 |
| ▸ | TUBB | P07437 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3973107 | 0.85 | ERN1 (0.45) | MAPTALDH1A1CA12CA1CA2 | |
| SCHEMBL7522484 | 0.84 | LMNA (0.48) | LMNAL3MBTL1MAPTMEN1KMT2A | |
| SCHEMBL31502538 | 0.83 | LMNA (0.47) | LMNAL3MBTL1MAPTMEN1KMT2A | |
| SCHEMBL17091203 | 0.83 | LMNA (0.47) | LMNAL3MBTL1MAPTMEN1KMT2A | |
| SCHEMBL11922986 | 0.82 | MAPT (0.44) | LMNAL3MBTL1MAPTMEN1KMT2A | |
| SCHEMBL26493679 | 0.81 | CA12 (0.50) | MAPTMEN1KMT2AALDH1A1ALOX15 | |
| SCHEMBL22980480 | 0.81 | LMNA (0.48) | LMNAL3MBTL1MAPTMEN1KMT2A | |
| SCHEMBL15729532 | 0.81 | PRKCZ (0.50) | LMNAMAPTALDH1A1SMN1; SMN2GAA | |
| SCHEMBL16041589 | 0.81 | CA12 (0.54) | LMNAL3MBTL1MAPTMEN1KMT2A | |
| SCHEMBL6905553 | 0.81 | ALDH1A1 (0.50) | LMNAMAPTMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119462608-A | Fused ring CYP11A1 inhibitors | 轩竹生物科技股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-111943823-A | Preparation method of metrafenone | 安徽工业大学 | 2020-11-17 | — | — | CN | disclosed |
| EP-3275861-A1 | TETRACYCLINE COMPOUNDS | Tetraphase Pharmaceuticals, Inc. (US) | 2018-01-31 | — | — | EP | disclosed |
| US-20170334841-A1 | TETRACYCLINE COMPOUNDS | TETRAPHASE PHARMACEUTICALS, INC. | 2017-11-23 | — | — | US | disclosed |
| US-20170334841-A1 | TETRACYCLINE COMPOUNDS | TETRAPHASE PHARMACEUTICALS, INC. | 2017-11-23 | — | — | US | disclosed |
| US-20170334841-A1 | TETRACYCLINE COMPOUNDS | TETRAPHASE PHARMACEUTICALS, INC. | 2017-11-23 | — | — | US | disclosed |
| EP-2470500-B1 | TETRACYCLINE COMPOUNDS | TETRAPHASE PHARMACEUTICALS INC (US) | 2017-10-04 | — | — | EP | disclosed |
| EP-2470500-B1 | TETRACYCLINE COMPOUNDS | TETRAPHASE PHARMACEUTICALS INC (US) | 2017-10-04 | — | — | EP | disclosed |
| US-9624166-B2 | Tetracycline compounds | TETRAPHASE PHARMACEUTICALS, INC. (US) | 2017-04-18 | — | — | US | disclosed |
| US-9624166-B2 | Tetracycline compounds | TETRAPHASE PHARMACEUTICALS, INC. (US) | 2017-04-18 | — | — | US | disclosed |
| CN-1495153-A | 2-methoxy diphenyl ketone compound intermediate and its preparation method | 谷 | 2004-05-12 | — | — | CN | disclosed |
| CN-1147456-C | Fungicidal 2-methoxybenzophenones | 谷 | 2004-04-28 | — | — | CN | disclosed |
| EP-1368343-A1 | 1-(2-METHOXYBENZYL)-3-BENZHYDRYLPIPERAZINES AS TACHYKININ ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-12-10 | — | — | EP | disclosed |
| WO-2002055518-A1 | 1-(2-METHOXYBENZYL)-3-BENZHYDRYLPIPERAZINES AS TACHYKININ ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-07-18 | — | — | WO | disclosed |
| EP-0897904-B1 | Fungicidal 2-methoxybenzophenones | BASF AG (DE) | 2002-02-20 | — | — | EP | disclosed |
| US-6001883-A | SUBSTITUTED BENZOPHENONES OF GIVEN FORMULA, SUCH AS 6,6'-DIMETHYL-2,2',3',4'-TETRAMETHOXY-5-TRIFLUOROMETHYL-BENZOPHENONE; HIGHLY SYSTEMIC FUNGICIDES; CONTROLLING FUNGAL DISEASE SUCH AS POWDERY MILDEW IN PLANTS | AMERICAN CYANAMID COMPANY (US) | 1999-12-14 | — | — | US | disclosed |
| US-5945567-A | Fungicidal 2-methoxybenzophenones | AMERICAN CYANAMID COMPANY (US) | 1999-08-31 | — | — | US | disclosed |
| US-5922905-A | INTERMEDIATES FOR FUNGICIDES | AMERICAN CYANAMID COMPANY (US) | 1999-07-13 | — | — | US | disclosed |
| CN-1217317-A | Fungicidal 2-methoxybenzophenones | AMERICAN CYANAMID CO (US) | 1999-05-26 | — | — | CN | disclosed |
| EP-0897904-A1 | Fungicidal 2-methoxybenzophenones | American Cyanamid Company (US) | 1999-02-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170334841-A1 | TETRACYCLINE COMPOUNDS | TUBB, TUBA1A, TUBA1C | LMNA 3276/4885L3MBTL1 4735/4885MAPT 93/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.